Thursday, 20 November 2025
  
Login

Australia's most trusted
source of pharma news

Thursday, 20 November 2025
News

March PBAC Agenda drops early

Posted 20 November 2025 AM

The March PBAC Agenda dropped a week early with 32 companies chasing the first recommendations of 2026 for 21 new listings and 22 change to listings.

Novartis had the highest number of submissions at three - with nine other companies lining up two drugs for the PBACs consideration.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (2)

Sales & Customer Relations (13)

Clinical & Medical, R&D (5)

Regulatory, Pharmacovigilance & QA (5)

Other (12)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.